ArticleEuropean journal of dentistry2026
Nanoparticle Saltwater Fish Powder and Cell Protein Pathways in Enamel Density Enhancement.
Article in European journal of dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to evaluate the effect of nanoparticle saltwater fish powder on amelogenin expression and FABP-3 levels in fetal mice, with the goal of enhancing enamel density and supporting tooth mineralization. To date, this relationship has not been clearly explained in previous studies. Materials and Methods: This randomized experimental study involved 16 pregnant mice, divided into two groups: control and treatment. The treatment group received nanoparticle saltwater fish powder (2.14 mg/mL) orally three times daily, while the control group received distilled water. On gestational day 18, placental and fetal jaw tissues were collected. Amelogenin and FABP-3 expressions were analyzed by immunohistochemistry (IHC), while enamel density was assessed using micro-computed tomography (µCT). Statistical Analysis: Data were analyzed using SPSS 26 and presented as mean ± SD. Group differences were tested using an independent Results: IHC analysis revealed significantly increased amelogenin expression in the treatment group receiving nanoparticle saltwater fish powder (4.34 ± 3.26) compared to the control group (0.49 ± 0.40), with a Conclusion: Nanoparticle saltwater fish powder modulates amelogenin expression during enamel secretion and enhances FABP-3 expression, suggesting potential benefits for promoting enamel development through nutritional interventions. Moreover, µCT analysis revealed an increase in the mean enamel density.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.